Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Low serum levels of CCL2 are associated with worse prognosis in patients with Acute Coronary Syndrome: 2-year survival analysis

Full text
Author(s):
Lacerda Leocadio, Paola Caroline [1] ; dos Reis Menta, Penelope Lacrisio [1] ; Silva Dias, Melissa Tainan [1] ; Fraga, Julia Rodrigues [1] ; Goulart, Alessandra Carvalho [2] ; Santos, Itamar Souza [3, 2] ; Lotufo, Paulo Andrade [3, 2] ; Bensenor, Isabela Martins [3, 2] ; Alvarez-Leite, Jacqueline Isaura [1]
Total Authors: 9
Affiliation:
[1] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG - Brazil
[2] Univ Sao Paulo, Hosp Univ, Ctr Pesquisa Clin & Epidemiol, Sao Paulo - Brazil
[3] Univ Sao Paulo, Fac Med, Dept Clin Med, Sao Paulo - Brazil
Total Affiliations: 3
Document type: Journal article
Source: BIOMEDICINE & PHARMACOTHERAPY; v. 109, p. 1411-1416, JAN 2019.
Web of Science Citations: 0
Abstract

Inflammation is very important in Acute Coronary Syndrome (ACS) as well as in cardiac remodeling after an acute myocardial infarction (MI). Our study examined the prognostic value of Chemokine (C-C motif) ligand 2 (CCL2) in patients with ACS in the ERICO (Strategy of Registry of Acute Coronary Syndrome) study. We evaluated serum samples from 803 patients. The prognostic value of CCL2 was evaluated at the 2-year follow-up, according to cutoff points established by the median. Kaplan-Meier curves and Cox regression were used for analysis of all-cause mortality, cardiovascular mortality, and a combined outcome of fatal myocardial infarction or new non-fatal MI. There were 115 deaths from all causes, 78 deaths due to cardiovascular causes and 67 events in combined outcomes. CCL2 levels below the median (<= 100.9 pg/mL) were associated with increased risk of MI death or new non-fatal MI, even after model adjustment. Low serum levels of CCL2 shows a significant association with fatal or new non-fatal MI. (AU)

FAPESP's process: 12/14804-1 - Evaluation of prognostic factors associated to acute coronary syndrome at hospital admission and after 30 days in the study "Strategy of registry in acute coronary syndrome study" (ERICO)
Grantee:Isabela Judith Martins Bensenor
Support Opportunities: Regular Research Grants